Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content with a minimal header and a Home link. This indicates access to the study record is blocked rather than updated with new study information.SummaryDifference20%

- Check20 days agoChange DetectedRevision metadata on the study page was updated from v3.6.6 to v3.7.0. This indicates a software update to the page rendering or underlying platform rather than changes to the study content.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, signaling a minor update to the page version.SummaryDifference0.1%

- Check56 days agoChange DetectedThe site’s revision tag changed from v3.6.4 to v3.6.5, reflecting a minor system update with no impact to the study content or user-facing information.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now lists Revision: v3.6.4, indicating a deployment update to the ClinicalTrials.gov Study Details page. This update reflects a behind-the-scenes change rather than any modification to the study details or user-facing content.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page’s software version was updated from v3.6.0 to v3.6.3, indicating a backend patch. The change does not impact the displayed study details or user-facing functionality.SummaryDifference0.1%

Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.